We performed a randomized , masked , multicenter study comparing Darbe ( 10 g/kg , 1/week subcutaneously ) , Epo ( 400 U/kg , 3/week subcutaneously ) , and placebo ( sham dosing 3/week ) given through 35 weeks ' postconceptual age , with transfusions administered according to a standardized protocol .